Skip to main content

Peer Review reports

From: CCNB1 is a novel prognostic biomarker and promotes proliferation, migration and invasion in Wilms tumor

Original Submission
3 Mar 2023 Submitted Original manuscript
8 Apr 2023 Reviewed Reviewer Report - Defu Liu
8 Apr 2023 Reviewed Reviewer Report
12 Apr 2023 Reviewed Reviewer Report
17 Apr 2023 Reviewed Reviewer Report
15 May 2023 Author responded Author comments - Feng Liu
Resubmission - Version 2
15 May 2023 Submitted Manuscript version 2
26 May 2023 Author responded Author comments - Feng Liu
Resubmission - Version 3
26 May 2023 Submitted Manuscript version 3
10 Jun 2023 Author responded Author comments - Feng Liu
Resubmission - Version 4
10 Jun 2023 Submitted Manuscript version 4
24 Jun 2023 Author responded Author comments - Feng Liu
Resubmission - Version 5
24 Jun 2023 Submitted Manuscript version 5
25 Jul 2023 Reviewed Reviewer Report - Defu Liu
29 Jul 2023 Reviewed Reviewer Report
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
5 Aug 2023 Editorially accepted
17 Aug 2023 Article published 10.1186/s12920-023-01627-3

You can find further information about peer review here.

Back to article page